Cargando…

Cardiovascular and renal efficacy and safety of sodium-glucose cotransporter-2 inhibitors in patients without diabetes: a systematic review and meta-analysis of randomised placebo-controlled trials

OBJECTIVES: To assess the cardiovascular and renal efficacy and safety of sodium-glucose cotransporter-2 (SGLT2) inhibitors in patients without diabetes. METHODS: We searched PubMed, MEDLINE, Embase and Cochrane Library for publications up to 17 August 2022. Certainty of evidence was assessed using...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsai, Wan-Chuan, Hsu, Shih-Ping, Chiu, Yen-Ling, Yang, Ju-Yeh, Pai, Mei-Fen, Ko, Mei-Ju, Tu, Yu-Kang, Hung, Kuan-Yu, Chien, Kuo-Liong, Peng, Yu-Sen, Wu, Hon-Yen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577928/ https://www.ncbi.nlm.nih.gov/pubmed/36241355 http://dx.doi.org/10.1136/bmjopen-2021-060655

Ejemplares similares

Acute effects of dietary phosphorus intake on markers of mineral metabolism in hemodialysis patients: post hoc analysis of a randomized crossover trial
por: Tsai, Wan-Chuan, et al.
Publicado: (2021)

Altered Monocytic Phenotypes are Associated with Uraemic Pruritus in Patients Receiving Haemodialysis
por: KO, Mei-Ju, et al.
Publicado: (2021)

Prognostic importance and determinants of uremic pruritus in patients receiving peritoneal dialysis: A prospective cohort study
por: Wu, Hon-Yen, et al.
Publicado: (2018)

Reappraisal of effects of serum chemerin and adiponectin levels and nutritional status on cardiovascular outcomes in prevalent hemodialysis patients
por: Chen, Hung-Yuan, et al.
Publicado: (2016)

Risk Factors for Development and Progression of Chronic Kidney Disease: A Systematic Review and Exploratory Meta-Analysis
por: Tsai, Wan-Chuan, et al.
Publicado: (2016)

Physician Compliance With a Computerized Clinical Decision Support System for Anemia Management of Patients With End-stage Kidney Disease on Hemodialysis: Retrospective Electronic Health Record Observational Study
por: Yang, Ju-Yeh, et al.
Publicado: (2023)

A Comparison of Uremic Pruritus in Patients Receiving Peritoneal Dialysis and Hemodialysis
por: Wu, Hon-Yen, et al.
Publicado: (2016)

Risk of Skin Cancer among Patients with Chronic Kidney Disease Treated with Ultraviolet B Phototherapy for Uraemic Pruritus: A Nationwide Cohort Study
por: KO, Mei-Ju, et al.
Publicado: (2021)

Adverse events following the first, second and third doses of a COVID-19 vaccine in hemodialysis patients
por: Pai, Mei-Fen, et al.
Publicado: (2023)

Triglyceride to High-Density Lipoprotein Cholesterol Ratio Predicts Cardiovascular Outcomes in Prevalent Dialysis Patients
por: Chen, Hung-Yuan, et al.
Publicado: (2015)

Serum Fetuin A and Chemerin Levels Correlate with Hepatic Steatosis and Regional Adiposity in Maintenance Hemodialysis Patients
por: Chen, Hung-Yuan, et al.
Publicado: (2012)

Relationship between Fetuin A, Vascular Calcification and Fracture Risk in Dialysis Patients
por: Chen, Hung Yuan, et al.
Publicado: (2016)

Accuracy of a Nutrient Database in Estimating the Dietary Phosphorus-to-Protein Ratio and Using a Boiling Method in Low-Phosphate Hospital Diets
por: Tsai, Wan-Chuan, et al.
Publicado: (2018)

The roles of sodium-potassium-chloride cotransporter isoform-1 in acute lung injury
por: Hsieh, Po-Chun, et al.
Publicado: (2021)

Sodium-glucose cotransporter-2 inhibitors use and the risk of gout: a systematic review and meta-analysis
por: Lai, Shih-Wei, et al.
Publicado: (2023)

Fibroblast Growth Factor 1 Reduces Pulmonary Vein and Atrium Arrhythmogenesis via Modification of Oxidative Stress and Sodium/Calcium Homeostasis
por: Lu, Yen-Yu, et al.
Publicado: (2022)

Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis
por: Wu, Hon-Yen, et al.
Publicado: (2013)

Uremic pruritus: pathophysiology, clinical presentation, and treatments
por: Ko, Mei-Ju, et al.
Publicado: (2023)

Visceral adiposity index and risks of cardiovascular events and mortality in prevalent hemodialysis patients
por: Chen, Hung-Yuan, et al.
Publicado: (2014)

Corrigendum: Systolic blood pressure as the mediator of the effect of early menarche on the risk of coronary artery disease: A Mendelian randomization study
por: Fan, Hsien Yu, et al.
Publicado: (2023)

Pleiotropic effect of sodium-glucose cotransporter 2 inhibitors on blood pressure
por: Kao, Ting-Wei, et al.
Publicado: (2022)

Combined Alkaline Phosphatase and Phosphorus Levels as a Predictor of Mortality in Maintenance Hemodialysis Patients
por: Chang, Jia-Feng, et al.
Publicado: (2014)

Dietary Sodium Intake and Risk of Cardiovascular Disease: A Systematic Review and Dose-Response Meta-Analysis
por: Wang, Yi-Jie, et al.
Publicado: (2020)

Systolic blood pressure as the mediator of the effect of early menarche on the risk of coronary artery disease: A Mendelian randomization study
por: Fan, Hsien-Yu, et al.
Publicado: (2023)

Diagnostic Effect of Attenuation Correction in Myocardial Perfusion Imaging in Different Coronary Arteries: A Systematic Review and Meta-Analysis
por: Huang, Jei-Yie, et al.
Publicado: (2021)

Comparative Study of Outcomes among Patients with Polycystic Kidney Disease on Hemodialysis and Peritoneal Dialysis
por: Yang, Ju-Yeh, et al.
Publicado: (2015)

Outcome Comparisons Between Patients on Peritoneal Dialysis With and Without Polycystic Kidney Disease: A Nationwide Matched Cohort Study
por: Yang, Ju-Yeh, et al.
Publicado: (2015)

Correction: Uremic Pruritus, Dialysis Adequacy, and Metabolic Profiles in Hemodialysis Patients: A Prospective 5-Year Cohort Study
por: Ko, Mei-Ju, et al.
Publicado: (2013)

Uremic Pruritus, Dialysis Adequacy, and Metabolic Profiles in Hemodialysis Patients: A Prospective 5-Year Cohort Study
por: Ko, Mei-Ju, et al.
Publicado: (2013)

New insights and advances of sodium-glucose cotransporter 2 inhibitors in heart failure
por: Li, Juexing, et al.
Publicado: (2022)

Dipeptidyl peptidase 4 inhibitor use is associated with a lower risk of incident acute kidney injury in patients with diabetes
por: Chao, Chia-Ter, et al.
Publicado: (2017)

Sodium-Glucose Cotransporter 2 Inhibitors and Heart Failure: A Bedside-to-Bench Journey
por: Cappetta, Donato, et al.
Publicado: (2021)

Antiarrhythmic effects and mechanisms of sodium-glucose cotransporter 2 inhibitors: A mini review
por: Wu, Jinchun, et al.
Publicado: (2022)

Sodium–glucose cotransporter-2 inhibitor alleviated atrial remodeling in STZ-induced diabetic rats by targeting TLR4 pathway
por: Zhan, Xiaoping, et al.
Publicado: (2022)

Atrial fibrillation as a contributor to the mortality in patients with dementia: A nationwide cohort study
por: Chen, Yun-Yu, et al.
Publicado: (2023)

Potential favorable action of sodium-glucose cotransporter-2 inhibitors on sudden cardiac death: a brief overview
por: Sato, Tatsuya, et al.
Publicado: (2023)

Association between faecal haemoglobin concentration and the risk of cardiovascular diseases among Taiwanese adults in a community-based screening cohort
por: Chien, Kuo-Liong, et al.
Publicado: (2020)

Risk of hypovolemia associated with sodium–glucose cotransporter-2 inhibitors treatment: A meta-analysis of randomized controlled trials
por: Rong, Xi, et al.
Publicado: (2022)

The potential of sodium-glucose cotransporter 2 inhibitors for the treatment of systemic right ventricular failure in adults with congenital heart disease
por: Neijenhuis, Ralph M. L., et al.
Publicado: (2023)

In vivo Overexpression of Electrogenic Sodium/Bicarbonate Cotransporter (NBCe1) by AAV9 Modifies the Cardiac Action Potential and the QT Interval in Mice
por: Di Mattía, Romina A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j3jmt22anju68nmidgfiuf72m9